Drug details:
Molecular formula: C₁₉H₁₁Cl₃N₄O₃S₂

Standard name: 2-(2,1,3-benzothiadiazol-4-ylsulfonylamino)-5-chloro-N-(3,4-dichlorophenyl)benzamide

Curated SMILES: C1=CC2=NSN=C2C(=C1)S(=O)(=O)NC3=C(C=C(C=C3)Cl)C(=O)NC4=CC(=C(C=C4)Cl)Cl

Evidence for compound's anti-virulence activity:

Yersinia
Related VF: TTSS (Type III secretion system)
Target: Not determined
Drug effect: Blocks translocation of Yop effectors.
Max phase: Preclinical (in vitro)
Publication:
Kauppi AM, et al., 2003. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10(3):241-9.